ARMP Stock Summary and Trading Ideas (Armata Pharmaceuticals | AMEX:ARMP)

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Armata Pharmaceuticals trades on the AMEX stock market under the symbol ARMP.

As of June 8, 2026, ARMP stock price climbed to $7.57 with 24,620 million shares trading.

ARMP has a beta of 1.43, meaning it tends to be more sensitive to market movements. ARMP has a correlation of 0.03 to the broad based SPY ETF.

ARMP has a market cap of $277.78 million. This is considered a Small Cap stock.

In the last 3 years, ARMP traded as high as $16.34 and as low as $.90.

The top ETF exchange traded funds that ARMP belongs to (by Net Assets): VTI, VXF, IWC.

ARMP has outperformed the market in the last year with a return of +282.3%, while the SPY ETF gained +24.6%. However, in the most recent history, ARMP shares have underperformed the stock market with its stock returning -28.6% in the last 3 month period and -9.4% for the last 2 week period, while SPY has returned +10.2% and -0.9%, respectively.

ARMP support price is $6.92 and resistance is $8.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARMP shares will trade within this expected range on the day.